Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ifigenia Konstantinou
Observed name:
I. Konstantinou
Institution:
Bank of Cyprus Oncology Center
Observed institution:
Bank of Cyprus Oncology Center
ORCID:
0000-0003-3348-9044
Observed ORCID:
0000-0003-3348-9044
OpenAlex ID:
A5044919469
New Insights in the Era of Clinical Biomarkers as Potential Predictors of Systemic Therapy-Induced Cardiotoxicity in Women with Breast Cancer: A Systematic Review
2023
·
Alexia Alexandraki
, Elisavet Papageorgiou
, et al.
·
Cancers
·
25
PDF
Outcomes following potentially curative therapies for older patients with metastatic colorectal cancer
2020
·
Ifigenia Konstantinou
, Iestyn M. Shapey
, et al.
·
European Journal of Surgical Oncology
·
2
Comparison Between Alpelisib Plus Endocrine Therapy and Everolimus Plus Endocrine Therapy After CDK4/6 Inhibitors Progression in Patients with PIK3CA-Mutant Metastatic Breast Cancer: A Single-Center Retrospective Study
2026
·
Sotiris Loizidis
, Damianos Michaelides
, et al.
·
Cancers
·
1
PDF
Real-World Data on the Use of Cyclin-Dependent Kinase 4/6 Inhibitors in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced/Metastatic Breast Cancer
2026
·
Αntria Savvidou
, Anastasia Constantinidou
, et al.
·
World Journal of Oncology
PDF
Alpelisib Plus Endocrine Therapy Versus Everolimus Plus Endocrine Therapy After Cdk4/6 Inhibitor Failure in Pik3ca-mutant Advanced Breast Cancer
2025
·
Sotiris Loizidis
, Myria Galazi
, et al.
·
The Breast
Outcomes of treatment for non-metastatic rectal cancer; a ten year single institute experience at the Bank of Cyprus Oncology Centre (BOCOC)
2019
·
I. Konstantinou
, E. Xenophontos
, et al.
·
Annals of Oncology
Hematology QuizCase 40
2015
·
Loula Papageorgiou
, Vasileios I. Telonis
, et al.
Show more works
View as search
Works count:
7
Citation count:
28
H-index:
2
I10-index:
1
Year
Topic
Type